tm
Seeing Is Believing
tm
Seeing Is Believing
Poseida Therapeutics's activity chart (see below) currently has 30 price targets and 40 ratings on display.
Analysts average stock forecasts to be materialized ratio is 2.82% with an average time for these price targets to be met of 206.22 days.
Most recent stock forecast was given by from BTIG on 26-Nov-2024. First documented stock forecast 04-Aug-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-May-2021
$12
1 years 10 months 14 days ago
(26-Nov-2024)
0/2 (0%)
$9.14 (319.58%)
Buy Since 04-Jan-2023
$9
$-0.5 (-5.26%)
1 years 10 months 14 days ago
(26-Nov-2024)
0/5 (0%)
$-0.38 (-4.05%)
Buy Since 18-May-2021
$10
$0.5 (5.26%)
$10
2 years 10 days ago
(30-Sep-2024)
1/7 (14.29%)
$7.14 (249.65%)
928
Buy Since 01-Feb-2023
$14
3 years ago
(10-Oct-2023)
0/3 (0%)
$11.27 (412.82%)
Buy Since 07-Jan-2022
$24
$14.5 (152.63%)
$24
4 years 7 months 22 days ago
(18-Feb-2022)
0/2 (0%)
$20.07 (510.69%)
What is PSTX (Poseida Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on PSTX (Poseida Therapeutics)?
Which analyst has the current lower performing score on PSTX (Poseida Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PSTX (Poseida Therapeutics)?
Which analyst is the currently most bullish on PSTX (Poseida Therapeutics)?
Which analyst is the currently most reserved on PSTX (Poseida Therapeutics)?
